Picasso Kapital

Picasso Kapital AS is a strategic investment firm based in Harstad, Norway, focused on long-term investments. Historically, the firm specialized in the healthcare sector, actively seeking opportunities to enhance its portfolio. Through its investment strategies, Picasso Kapital aimed to generate sustainable growth and value over time.

Top Sectors

Finance Investment Banking Clinical Trials Medical Health Care Show more

Top Regions

Scandinavia Europe Oslo Nordic Europe Norway

http://www.picasso.no

https://crunchbase.com/organization/picasso-kapital

https://pitchbook.com/profiles/investor/229267-45

Knut Eidissen

Managing Director and Owner

1 past transactions

Lytix Biopharma

Venture Round in 2009

Lytix Biopharma ASA is a clinical-stage biotechnology company based in Oslo, Norway, with an additional office in Tromso. Founded in 2003, the company specializes in developing novel cancer immunotherapies that activate the immune system to combat cancer. Its lead product, LTX-315, is an oncolytic peptide designed to reshape the tumor microenvironment by releasing powerful immune stimulants and tumor antigens. In addition to LTX-315, the company is developing other products, such as LTX-401. Lytix Biopharma also offers research and development services in the fields of anti-microbials and cancer therapeutics.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.